by: Jonathan Benson
(NaturalNews) Several years after declaring it to be not only medically useless but also dangerous, the US Food and Drug Administration (FDA) has officially withdrawn approval for the $100,000 breast cancer drug Avastin. In a statement, FDA Commissioner Margaret Hamburg said that Avastin has never been proven to be safe or effective, but also in the same breath noted that doctors can still prescribe the drug if they feel like it.
After being rapidly approved for use by the FDA back in 2007, Avastin quickly generated more than $1.7 billion for its producer Genentech within the first year. When the FDA finally got around to actually reviewing the drug after approving it, though, the agency discovered that Avastin does not lengthen the lives of breast cancer patients, and that it carries with it severe side effects that include death.
But the way the FDA is handling the situation shows how blatantly biased it is towards the drug industry. Avastin was proven dangerous and ineffective several years ago, but the FDA allowed it to remain on the market. Now, it has decided to withdraw approval for Avastin, but is still allowing it to remain on the market.
If Avastin had been a dietary supplement in the same predicament, the agency would have immediately withdrawn its approval (if it would have approved it in the first place), and demanded that it be removed from the market. The agency likely would have also shut down Avastin's manufacturer, as it has done a lot worse to supplement companies that produce safe and effective natural treatments.